Biotech companies are experiencing a surge in value, spurred by the convergence of advancements in artificial intelligence (AI) and life sciences. President Trump’s efforts to bolster domestic industries […]
YZi Labs Invests in Regenerative Medicine with Renewal Bio
YZi Labs, formerly Binance Labs, has made a strategic shift away from purely crypto-focused investments. The firm recently invested in Renewal Bio, a company developing Stembroid platform for […]
Propanc Biopharma Raises $100 Million for Crypto & Cancer Treatment
Propanc Biopharma, an Australian biotech firm, has secured a significant investment of up to $100 million from Hexstone Capital, a crypto-focused family office. This funding will be used […]
Propanc Biopharma Invests $100 Million in Crypto, Signaling Growing Institutional Trust
Nasdaq-listed Propanc Biopharma has taken a significant step into the world of cryptocurrency by securing up to $100 million specifically for digital asset purchases. This innovative move marks […]
Cogent Biosciences Soars 120%, Driven by Positive Cancer Drug Trial Results
Shares of Cogent Biosciences (NASDAQ: COGT) experienced a dramatic surge, climbing over 120% in premarket trading on November 10, 2025. This impressive jump followed the company’s announcement of […]
Tango Therapeutics Stock Plummets Following $210 Million Equity Offering
Shares of Tango Therapeutics (TNGX) experienced a significant decline on October 23, 2025, following the announcement of a substantial equity offering worth $210 million. The biotechnology company’s stock […]
OGRD Alliance Expands OncoVix and PLPC-DB Initiatives Across Asia and MENA
Dubai, United Arab Emirates – October 20th, 2025 – FinanceWire Following the licensing frameworks and international recognition of the PLPC Platform, the American-based biotechnology system led by Dr. […]
YZi Labs Launches EASY Residency Season 2: Empowering Web3, AI, & Biotech Startups Globally
YZi Labs (formerly Binance Labs) is kicking off the second season of its EASY Residency program, a global eight-week initiative designed to support entrepreneurs working in Web3, artificial […]
Leap Therapeutics Secures $58.88 Million for Cryptocurrency-Backed Treasury Strategy
Biotechnology firm Leap Therapeutics (Nasdaq: LPTX) has secured a significant funding boost of $58.88 million through a private investment in public equity (PIPE) transaction, paving the way for […]
Biotech Stocks Dip Amid Shift in Bitcoin Strategy
New strategies for utilizing cryptocurrency are shaking up the biotech sector. BitMine and SharpLink, two prominent companies in this field, have made significant investments in Ethereum (ETH), which […]
BioNTech Acquires CureVac: mRNA Therapeutics Giant Takes Aim at Cancer Immunotherapy
German biotech firm BioNTech has acquired its competitor, CureVac, in a $1.25 billion all-stock deal. This strategic move combines two leaders in the mRNA therapeutics space and signals […]
Brian Armstrong Invests $130 Million in Anti-Aging Startup NewLimit
Coinbase CEO Brian Armstrong is taking on two major challenges: the complexities of human aging and the evolving landscape of cryptocurrency regulation. He’s tackling these issues head-on by […]
NewLimit Secures $130 Million to Drive Age-Reversal Research
Biotech firm NewLimit, co-founded by Coinbase CEO Brian Armstrong, has secured a significant $130 million in funding through a Series B round. This investment from Kleiner Perkins will […]
NewLimit Secures $130 Million Series B Funding to Advance Anti-Aging Research
Biotechnology firm NewLimit has received a significant $130 million Series B funding round, led by the renowned venture capital firm Kleiner Perkins. This investment underscores the potential of […]